| Code | 2653F | ||||||||||
| MA number | 69/0032/26-S | ||||||||||
| Product Form: | pas ord 24x8,75 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oromucosal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 26.02.2026 |
| Validity: | 26.02.2031 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Oroflurb Neo pastilky s pomarančovou príchuťou_02.2026.pdf
|
| SPC: |
SPC_Oroflurb Neo pastilky s pomarančovou príchuťou_02.2026.pdf
|
| Safety feature | No |
| Data update: | 02.03.2026 |
